MENU
+Compare
ATYR
Stock ticker: NASDAQ
AS OF
Apr 10, 04:59 PM (EDT)
Price
$2.75
Change
-$0.12 (-4.18%)
Capitalization
243.47M

ATYR aTyr Pharma Inc Forecast, Technical & Fundamental Analysis

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ATYR with price predictions
Apr 09, 2025

ATYR in downward trend: price dove below 50-day moving average on March 25, 2025

ATYR moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATYR as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATYR turned negative on March 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for ATYR crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATYR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ATYR's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where ATYR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ATYR advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATYR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.477) is normal, around the industry mean (13.320). P/E Ratio (0.000) is within average values for comparable stocks, (62.790). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.760). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (833.333) is also within normal values, averaging (246.160).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATYR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ATYR is expected to report earnings to rise 5.56% to -18 cents per share on May 07

aTyr Pharma Inc ATYR Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.01
The last earnings report on March 13 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 1.27M shares outstanding, the current market capitalization sits at 243.47M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CYPIX51.18N/A
N/A
ProFunds Consumer Disctnry Ultra Sec Inv
TIMVX14.97N/A
N/A
Nuveen Mid Cap Value R6
AGORX8.29N/A
N/A
American Century Focused Global Gr R
TVOAX31.53N/A
N/A
Touchstone Small Cap Value A
HILRX17.68N/A
N/A
Hartford International Value R3

ATYR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+5.15%
MGTX - ATYR
44%
Loosely correlated
+2.39%
NTLA - ATYR
36%
Loosely correlated
+12.74%
SLDB - ATYR
35%
Loosely correlated
+2.62%
AMLX - ATYR
35%
Loosely correlated
+5.59%
CRNX - ATYR
35%
Loosely correlated
+8.18%
More